| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |